Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Bioreactors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026 - 2026

 

Bioreactors Market
Bioreactors Market

The bioreactors market is expected to expand as bioreactors are increasingly used in various R&D projects. Bioreactors are critical in the development and production of engineered biological products. They simulate the in vivo microenvironment of tissue growth while also providing mechanical and biochemical signals to stem cells in order for them to successfully generate transplantable organs or tissues.

Enzyme, vaccine, antibody, growth factor, and hormone manufacturing is a difficult task in which small differences in manufacturing conditions can have a significant impact on product quality, efficacy, safety, and yield. Because most commercial biopharmaceutical proteins are complex glycoproteins, they must be produced under strict conditions. Bioreactors help to manufacture biopharmaceuticals under controlled and repeatable conditions while adhering to GMP guidelines. This factor is expected to drive the bioreactors market even further.

In industrial processes, bioreactors are used to cultivate organisms (such as animal cells, mammalian cells, yeast cells, and bacteria) under controlled conditions and produce biopharmaceuticals such as monoclonal antibodies and vaccines, among other things. The potential applications and adoption of biological products in the healthcare industry are growing, driving demand for manufacturing space and bioreactors.

The single-use bioreactor is expected to be the most profitable segment. Single-use bioreactor systems are now widely used in biopharmaceutical manufacturing processes that prioritise high product yield. The flexibility, cost-effectiveness, and high mass production of single-use bioreactors will increase demand, affecting growth.

According to application, research and development is expected to be the most profitable segment. The Asia-Pacific region is expected to be the most profitable. Asian companies, both domestic and international, are estimated to be building roughly half of all new bioprocessing facilities worldwide. This is expected to be a major driving force in the Asia Pacific market in the near future. China is expected to be at the forefront due to its high adoption of single-use technology.

 

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027